THC-cannabis shows limited effectiveness for inflammatory bowel disease
Effectiveness of THC-containing cannabis for inflammatory bowel disease: a systematic review.
AI Summary
This systematic review examined whether THC-containing cannabis products could effectively treat inflammatory bowel disease (IBD), a condition where the digestive tract becomes chronically inflamed. Researchers analyzed four randomized controlled trials and four observational studies involving patients who used cannabis for IBD symptoms. The review followed rigorous scientific standards (PRISMA and Cochrane guidelines) to ensure credibility, though all studies examined had high risk of bias, limiting how much we can trust the results.
The findings were disappointingly inconclusive. While a small trial (n=56) reported improvements in bloating and appetite, most other outcomesβincluding disease remission, pain, nausea, weight, and bowel movement frequencyβshowed no meaningful differences between cannabis and control groups. Results for clinical disease activity scores, quality of life, and general well-being were mixed, with evidence quality ranging from low to moderate. Only weight showed high-quality evidence, but even then, there was no effect reported. The researchers emphasized that safety information was extremely limited across the trials.
The bottom line: despite widespread use of cannabis among IBD patients, current scientific evidence does not demonstrate that THC-containing products are effective for treating IBD. The researchers called for higher-quality, well-designed studies to better understand whether cannabis has any genuine therapeutic role. This review is particularly important because many IBD patients self-medicate with cannabis, making rigorous evidence crucial for informed decision-making.
π
Original Abstract
Related Research
Similar Studies
More THC research papers you might find interesting.
Small lab study finds cannabis affected simulated driving and confidence
A lab method measures 17 cannabinoids across five hemp product types
A single-center study finds varied care and no recurrence in follow-up
Explore More Research
Stay informed about the latest cannabis science.